• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Drug Test Lab Pays $4.8 Million for Charging Medicaid above MFN Rate

Drug Test Lab Pays $4.8 Million for Charging Medicaid above MFN Rate

by Glenn S. Demby | Mar 28, 2022 | Articles, Essential, Lab Compliance Advisor, Labs in Court-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry

Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry

by Glenn S. Demby | Mar 28, 2022 | Articles, Essential, Lab Compliance Advisor, Labs in Court-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Feds Target Fraudulent Billing of Genetic Cancer Tests

Feds Target Fraudulent Billing of Genetic Cancer Tests

by Glenn S. Demby | Feb 24, 2022 | Articles, News, Open Content

False ordering and billing of cancer genetic (CGx) tests has become a favorite target for federal fraud enforcers, with the U.S. Department of Justice (DOJ) reporting two notable convictions in the closing months of 2021. On Nov. 17, a 57-year-old former lab sales rep...
Pain Clinic Operator Gets Permanent Exclusion for Billing Medically Unnecessary Tests

Pain Clinic Operator Gets Permanent Exclusion for Billing Medically Unnecessary Tests

by Glenn S. Demby | Dec 21, 2021 | Articles, Essential, Lab Compliance Advisor, Labs in Court-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Did Cigna Wait Too Long to Sue Reference Labs for Fraudulent Billing?

Did Cigna Wait Too Long to Sue Reference Labs for Fraudulent Billing?

by Glenn S. Demby | Dec 21, 2021 | Articles, Essential, Lab Compliance Advisor, Labs in Court-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com